ROCKVILLE, Md., Oct. 15, 2015 /PRNewswire/ -- Therabron Therapeutics, Inc., a specialty biotechnology company dedicated to redefining the management of respiratory disease through innovation, today announced that it will participate in two upcoming investor conferences. The conferences are:
- 14th Annual BIO Investor Forum - October 20 - 22, 2015 - Therabron President and Chief Operating Officer will present on October 21, 2015 in a session beginning at 8:30am PT in the Davidson Room at the Parc 55 Hotel in San Francisco, CA.
- The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies.
- BioNetwork Partnering Summit - October 26 - 28, 2015 - Therabron will participate in the two-day summit taking place at the Ritz Carlton Hotel in Laguna Niguel, CA.
- BioNetwork is considered an essential platform for business development executives across the pharmaceutical and biotechnology space to come together in a private setting and develop relationships that lead to strategic partnerships.
About Therabron Therapeutics, Inc.
Therabron Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2007 and located in Rockville, MD. Therabron is focused on the advancement of respiratory therapeutics with disease-modifying potential. The company's product candidates aim to restore the natural immune balance in the lungs of respiratory patients through the administration of recombinant human CC10 proteins. The family of CC10 proteins, also known as secretoglobins, have the potential to change the course of acute and chronic respiratory diseases, representing large markets into which few truly novel drugs have been introduced. Therabron's product candidates have the potential to be first-in-class, disease-modifying, breakthrough biologic therapeutics. For additional information, please visit www.therabron.com.
SOURCE Therabron Therapeutics, Inc.